William Febbo | Chief Executive Officer |
Ed Stelmakh | Chief Financial Officer |
Stephen Silvestro | Chief Commercial Officer |
Andrew D’Silva | Senior Vice President of Corporate Finance |
Ryan Daniels | William Blair |
Sean Dodge | RBC Capital Markets |
Marc Wiesenberger | B. Riley Securities |
Eric Martinuzzi | Lake Street |
Harvey Poppel | Poptech Capital LLP |
Good afternoon and thank you for joining OptimizeRx Fourth Quarter Fiscal 2021 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by Company Chief Financial Officer, Ed Stelmakh; Chief Commercial Officer, Stephen Silvestro; Executive Vice President of Finance and Accounting, Doug Baker; General Counsel and Chief Compliance Officer, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D’Silva. At the conclusion of today’s earnings call, I will provide some important cautions regarding the forward-looking statements made by management during today’s call. I would like to remind everyone that today’s call is being recorded and will be made available for replay via webcast only.